No Data
No Data
Synlogic Q2 2024 GAAP EPS $0.16 Beats $(0.36) Estimate, Cash And Cash Equivalents Of $20M
Press Release: Synlogic Reports Second Quarter 2024 Financial Results
Synlogic | 10-Q: Q2 2024 Earnings Report
Synthetic Immunology Market Report 2024 With Profiles of ADC Therapeutics, BioNTech, Camena Bioscience, CRISPR Therapeutics, Editas Medicine, Sherlock Biosciences, Synlogic Therapeutics & Synthego
Hold Rating Maintained for Synlogic Amidst Setbacks and Financial Uncertainties
Synlogic Flat on Q1 Numbers
No Data
Jaguar8 : Yikes.